The partnership will involve the sharing of scientific and technological information; increased cooperation with nongovernmental organizations, academic institutions and grassroot organizations; the organization of training programs, seminars and workshops; and the execution of joint projects.

The MoU was signed virtually by Danish Health Minister Magnus Heunicke and his Indonesian counterpart Budi Gunadi Sadikin on June 25. Also attending the ceremony were Danish Ambassador to Jakarta Lars Bo Larsen and Indonesian Ambassador to Copenhagen Dewi Savitri Wahab, the Indonesian Health Ministry announced.

Budi welcomed the MoU and said he expected it to be useful for both countries in the improvement of health care, while Heunicke expressed Denmark’s readiness to support Indonesia in its efforts to improve the health sector.

In addition, an agreement between the Health Ministry and PT Novo Nordisk Indonesia, the local subsidiary of a Danish pharmaceutical company, was signed during the ceremony. It regarded the prevention and control of noncommunicable diseases, especially diabetes, and was a concrete result of the MoU, the ministry said.

Health Ministry secretary general Oscar Primadi and PT Novo Nordisk Indonesia vice president and general manager Anand Shetty signed the agreement, which covers raising public awareness about diabetes; improving health workers’ ability to treat the condition; expanding access to health services for people with noncommunicable diseases; and evaluating health economics related to diabetes. 

Novo Nordisk Indonesia was appointed the strategic partner in the agreement between Denmark and Indonesia to pursue these changes.

Popular

Analysis: Prabowo’s approval rating 51 percent and falling

A healthy economy must be felt

Poverty falls, but the line is too low, economists say